期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (3)
The research work was aimed to formulate and evaluate gastroretentive mucoadhesive film of calcium channel blocker, Lacidipine for treatment of gastro......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (7)
Fluorescence is routinely used to monitor kinase inhibition in commercial assays. Occasionally fluorescent compounds can interfere with the fluorescen......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (1)
Drug absorption is improved by the intranasal route's wide surface area and avoidance of first-pass metabolism. For the treatment of central nervous s......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (3)
A highly selective, sensitive, rugged, and rapid ultra high-performance liquid chromatography-tandem mass spectrometry method (UPLC-MS/MS) is optimize......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (8)
Present research work reports the development of doxorubicin (DOX) loaded alpha-tocopherol polyethylene glycol 1000 succinate (TPGS)-coated cationic l......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (8)
Effective drug delivery to target sites is critical for achieving desired therapeutic outcomes. However, the poor permeability of certain drugs poses ......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (5)
Ligand-receptor interactions (LRIs) are the basis for all the biological processes taking place in living cells and have been exploited to develop and......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (7)
Lacidipine, a calcium channel antagonist, is primarily used to treat hypertension. It is classified as a Biopharmaceutics Classification System Class ......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (2)
Poorly soluble drug molecules/phytoconstituents are still a growing concern for biopharmaceutical delivery in the body. Polymeric micelles are the amp......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (3)
The current pharmaceutical manufacturing scenario involves different techniques for the processing of materials. For example, the extraction unit is o......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; ()
A reverse-phase high-performance liquid chromatographic (RP-HPLC) method was developed to analyze the simultaneous estimation of doxorubicin and clotr......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (4)
A series of oxadiazole-based five-membered heterocyclic derivatives was designed and synthesized with the intent of exclusive cyclo-oxygenase-2 (COX-2......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (7)
The purpose of this study was to apply the quality by design (QbD) approach in the development of a microbial and pH-triggered colon-targeted budesoni......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (4)
Candidosis is one of the most frequent opportunistic infections and exhibits variable clinical presentations, including oral localized forms. Drugs af......
期刊： ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2023; 21 (4)
Continuous drug delivery modification is the scientific approach and is a basic need for the efficient therapeutic efficacy of active drug molecules. ......
